This healthcare startup raises $1 million to deal with India’s rising intestine and liver issues
A healthcare startup centered on gastroenterology, liver and metabolic care has raised $1 million (round ₹9 crore) in a seed funding spherical backed by a consortium of greater than 15 buyers, together with healthcare professionals and trade members.
Intestine Clinic mentioned the spherical included buyers resembling Dr Amitoj Singh, Dr Aman Rajpal, Ankur Kathuria of Alpha Wave International, Juhi Bhatnagar of Forj Capital, and Deepak Garg, Senior Government Vice President at Reliance Industries.
The funding comes amid a rising burden of lifestyle-related digestive and metabolic issues in India, with estimates suggesting round 70 million persons are affected. A lot of the present care ecosystem stays hospital-led and reactive, with restricted give attention to early-stage analysis and long-term administration.
The corporate is engaged on an outpatient-led mannequin supported by know-how and standardised remedy protocols. The method goals to shift a part of the care supply outdoors acute hospital settings, whereas nonetheless integrating with day-care and in-hospital companies the place crucial.
The capital might be used to arrange further centres, strengthen scientific methods and develop diagnostic capabilities. The broader preventive healthcare section in India is estimated to be price about $197 billion, although it stays fragmented.
“This funding permits us to strengthen the scientific methods required to ship constant, high-quality outpatient care at scale,” mentioned Dr. Akshat Kumar, Founder and CEO of Intestine Clinic. “We aren’t seeking to change hospitals, however to enhance them by managing continual and preventive gastro, liver and metabolic circumstances extra successfully outdoors acute settings. With gastrointestinal issues on the rise, liver illness among the many main causes of mortality, and fatty liver affecting almost one in three Indians, it’s the want of the hour to carry our world-class clinicians nearer to sufferers’ properties.”
Intestine Clinic was based by Dr. Akshat Kumar, a US-certified doctor and Wharton MBA who beforehand labored in world scientific operations at McKinsey. The enterprise additionally attracts on the scientific background of Dr. Ajay Kumar, a B.C. Roy Awardee and Chairman at Pan Max, Gastroenterology & Hepatology India.
The startup has an advisory board that features Dr. Nageshwar Reddy of AIG Hospitals and Dr. Suresh Chari. The founding staff additionally contains Dr. Manav Wadhawan as Chief Technique and Medical Officer.
At present working within the Delhi NCR area, the corporate plans to develop to Chandigarh, Punjab and different elements of northern India, with a goal of organising over 20 centres within the close to to medium time period.
